INSTITUTE FOR CLINICAL RESEARCH INC (EIN 521336656) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1984

Legal Domicile

Principal Officer

FELIX OLIVER

Phone

2024626820

Tax Period

2024-01-01 to 2024-12-31

INSTITUTE FOR CLINICAL RESEARCH INC, founded in 1984, is a community nonprofit in the Medical Research sector that reported $4.3M in total revenue in fiscal year 2024. Revenue decreased 7% compared to the prior year. Expenses of $4.9M exceeded revenue, resulting in a 16% operating deficit.

Mission

TO SUPPORT AND PERFORM MEDICAL AND PHARMACOLOGICAL RESEARCH, RELATED EDUCATIONAL ACTIVITIES AND OTHER RELATED ENDEAVORS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $1,613,685

Program Service Revenue $2,379,878

Investment Income $262,044

Other Revenue $4,327

TOTAL REVENUE $4,259,934

Expense Breakdown

Grants Paid $1,409,189

Salaries & Benefits $2,294,037

Fundraising Expenses $54,187

Program Expenses $3,928,535

Other Expenses $1,226,276

TOTAL EXPENSES $4,929,502

Year-over-Year Comparison

	2024	2023	Change
Revenue	$4,259,934	$4,582,631	-0.1%
Expenses	$4,929,502	$4,389,089	+0.1%
Net Income	$-669,568	$193,542	-4.5%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✗ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$494,056

Total Directors

$2,889,386

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
FELIX OLIVER	EXECUTIVE DIRECTOR/CEO	20.00	Officer	$180,902	$1,845	$182,747
MICHAEL VJECHA	SCIENCE ADMINISTRATOR	40.00	Highest	$179,140	$18,922	$198,062
ADRIANA SANCHEZ	ID RESEARCH MANAGER	40.00	Highest	$149,241	$15,457	$164,698
GAIL KERR MD	CHAIRMAN	2.00	Officer Director	$0	$0	$311,309
PAMELA KARASIK MD	DIRECTOR	1.00	Director	$0	$0	$395,723
SAMIR PATEL MD	DIRECTOR	1.00	Director	$0	$0	$328,279
CHARLES FASELIS MD	DIRECTOR	1.00	Director	$0	$0	$324,544
SAMANTHA MCINTOSH MD	DIRECTOR	1.00	Director	$0	$0	$321,207
MATTHEW TUCK MD	DIRECTOR	1.00	Director	$0	$0	$283,759
ANGELIKE LIAPPIS MD	DIRECTOR	1.00	Director	$0	$0	$268,875
COL RET MICHAEL S HEIMALL	DIRECTOR	1.00	Director	$0	$0	$230,436
DANIEL TAUB PHD	DIRECTOR	1.00	Director	$0	$0	$191,900
BIDHAN BANDYOPADHYAY PHD	DIRECTOR	1.00	Director	$0	$0	$153,354
JOAO ASCENSAO MD	DIRECTOR	1.00	Director	$0	$0	$80,000
MELVIN GOODWEATHER	DIRECTOR	1.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$4,259,934	$4,929,502	$12,649,635	$-669,568
2023	$4,582,631	$4,389,089	$13,306,079	$193,542
2022	$6,536,173	$5,961,090	$14,785,440	$575,083
2021	$12,644,363	$10,809,919	$20,629,782	$1,834,444
2020	$6,193,738	$6,313,935	$13,491,504	$-120,197
2019	$2,537,022	$3,083,851	$10,261,770	$-546,829
2018	$4,506,522	$3,820,928	$10,982,344	$685,594

INSTITUTE FOR CLINICAL RESEARCH INC